BR112013027075A2 - 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares - Google Patents

4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares

Info

Publication number
BR112013027075A2
BR112013027075A2 BR112013027075A BR112013027075A BR112013027075A2 BR 112013027075 A2 BR112013027075 A2 BR 112013027075A2 BR 112013027075 A BR112013027075 A BR 112013027075A BR 112013027075 A BR112013027075 A BR 112013027075A BR 112013027075 A2 BR112013027075 A2 BR 112013027075A2
Authority
BR
Brazil
Prior art keywords
butanoates
haloalkyl
ammonium
treatment
cardiovascular disease
Prior art date
Application number
BR112013027075A
Other languages
English (en)
Inventor
Daina Gustina
Daina Lola
Edgars Liepins
Einars Loza
Ilmars Stonans
Ivars Kalvins
Janis Kuka
Maija Dambrova
Marina Makrecka
Osvalds Pugovics
Solveiga Grinberga
Viktors Andrianovs
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of BR112013027075A2 publication Critical patent/BR112013027075A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo "4-[(haloalquil)-(dimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares" a presente invenção refere-se aos 4-[(haloalquil)-(dimetil)- amônio] butanoatos, de fórmula (i), onde hal é cl ou f, n = 1 ou 2, seus processos de preparação dos mesmos e seus usos no tratamento de doenças cardiovasculares. [pic]
BR112013027075A 2011-04-27 2012-04-27 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares BR112013027075A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11163838 2011-04-27
EP11163837 2011-04-27
EP11163842 2011-04-27
PCT/EP2012/057807 WO2012146737A1 (en) 2011-04-27 2012-04-27 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease

Publications (1)

Publication Number Publication Date
BR112013027075A2 true BR112013027075A2 (pt) 2016-12-27

Family

ID=46046159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027075A BR112013027075A2 (pt) 2011-04-27 2012-04-27 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares

Country Status (8)

Country Link
US (1) US8940793B2 (pt)
EP (1) EP2702037A1 (pt)
CN (1) CN103547562A (pt)
AU (1) AU2012247468A1 (pt)
BR (1) BR112013027075A2 (pt)
EA (1) EA201301079A1 (pt)
WO (1) WO2012146737A1 (pt)
ZA (1) ZA201307847B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV14345B (lv) * 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (pt) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
LV13280B (en) * 2003-08-04 2005-11-20 Grindeks Publiska As Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN102803199B (zh) * 2009-06-25 2015-04-15 泰特拉有限公司 乙酰水杨酸盐

Also Published As

Publication number Publication date
WO2012146737A1 (en) 2012-11-01
US20140107202A1 (en) 2014-04-17
EP2702037A1 (en) 2014-03-05
US8940793B2 (en) 2015-01-27
AU2012247468A1 (en) 2013-11-14
CN103547562A (zh) 2014-01-29
EA201301079A1 (ru) 2014-02-28
ZA201307847B (en) 2014-11-26

Similar Documents

Publication Publication Date Title
BR112013026427A2 (pt) inibidores de replicação viral, seu processo de preparação e seus usos terapêuticos
BR112013029976A2 (pt) 4-aril-n-fenil-1,3,5-triazin-2-aminas contendo um grupo sulfoximina
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
ECSP14013224A (es) Pirimidinas anilladas sustituidas y uso de las mismas
EA201590890A1 (ru) Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу
BR112012032778A2 (pt) "proteínas multiespecíficas e multivalentes"
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
UA110054C2 (uk) Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування
DK2483255T3 (da) Oxazinderivater samt deres anvendelse ved behandling af neurologiske lidelser
BRPI1007476A2 (pt) análogos de ciclosporina para prevenir ou tratar infecção por hepatite c
BR112014017751A8 (pt) compostos inibidores de metaloenzima, métodos de inibir e modular a atividade de metaloenzina, composições contendo os ditos compostos e uso dos ditos compostos
EA201790032A1 (ru) Бициклически замещённые урацилы и их применение
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
BR112012016492A2 (pt) "artigo do vestuário descartavel"
BR112014000357A2 (pt) artigos que incluem fibras multicomponentes e partículas, e método de preparo e utilização dos mesmos
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
WO2014060493A3 (en) N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
BRPI0922698A2 (pt) controle eficaz de doença viral em plantas com cepas de pseudomonas oleovorans
BR112014000889A2 (pt) tratamento para hipoxia
BR112015032379A2 (pt) inibidores virais de replicação, seu processo de preparação e suas utilizações terapêuticas
BR112013027075A2 (pt) 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares
BRPI0913071A2 (pt) forma grande de 2,5-oligoadenilato sintetase oas3 humana para prevenir ou tratar infecção por vírus com rna de fiota simples com senso positivo
BR112013027065A2 (pt) processo para a preparação de sais de 3-carboxi-n-etil-n,n-dimetilpropan-1amínio, compostos e seus usos
BR112014030594A2 (pt) "processo e reator térmico de propulsão mono válvula com injeção e combustão múltiplas por ciclo de rotação"

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)